The U.S. Department of Health and Human Services, DHHS, issued a news release on September 16, 2016, announcing a final rule that will go into effect on January 18, 2017. The final DHHS Rule affects medical related clinical trials. Researchers will have 90 days to comply. The new rule expands the existing rule on the
John Henricks, a former inmate of the Ohio state prison system, was awarded a $3 million dollar settlement by a jury earlier this week after the state failed to answer his complaint in the appropriate amount of time. Henricks, who initially represented himself when he filed the case, accused Dr. Ida Gonzalez, along with the
When the revelation of a long-buried conspiracy by the sugar industry to blame fat for sugar-related health problems came to light last week, many heads nodded knowingly. There have been whispers for years about the topsy-turvy health advice handed down by the mainstream media and health establishment, recommending low-fat diets for people who wanted to live
In 2007, 12-year-old Deamonte Driver died from a preventable brain infection. The Maryland youth suffered from a tooth infection that spread to his brain after his family, who had difficulty finding a dentist who would take Medicaid before their coverage lapsed, was unable to afford dental care. After Deamonte’s death, then-Maryland governor Martin O’Malley introduced
On September 2, 2016, the Food and Drug Administration, FDA, enacted a final rule banning the sale of some antibacterial soaps. The ban includes liquid and bar soaps containing, among other active chemicals, the most commonly used triclosan and triclocarban. The manufacturers could not prove that the antibacterial soaps were any more effective than regular
In yet another unsurprising case of Big Pharma trying to control the fate of millions of Americans’ health, Insys Therapeutics has donated $500,000 to an anti-legalization of marijuana campaign in Arizona known as Proposition 205. Pro-legalization advocates view the half million dollar donation as a further attempt to line the pockets of powerful drug corporations
The Drug Enforcement Administration, DEA, published a notice on August 31, 2016, of its intent to temporarily schedule Kratom as a Schedule I drug. According to the DEA, the measure is needed to “avoid imminent hazard to public safety”. Schedule I includes heroin and other dangerous drugs. That rule is scheduled to become effective September
In January, 2016, the U.S. Attorney’s Office in the Northern District of Texas issued a press release announcing that arrests had been made in what was dubbed as the “Dallas Pill Mill”. U.S. Attorney John Parker stated that the arrests were in relation to a conspiracy to illegally distribute controlled substances. The drugs involved included
According to the Seattle Times, the U.S. Drug Enforcement Administration has decided to keep marijuana and its derivatives classified as a Schedule 1 drug. That class of drugs includes heroin and other dangerous drugs that have no medical value. That ruling caused the marijuana health benefits controversy to rage on! That decision flies in the
According to its September 7, 2016, press release, St. Jude Medical filed a lawsuit against MedSec and Muddy Waters Consulting, MedSec Holdings, Muddy Waters Capital, and three principals in those firms. The suit was filed in the U.S. District Court in Minnesota. St. Jude Medical’s, SJM, allegations include “false statements, false advertising, conspiracy and the